TrialDrugs in R&D2025

Assessment of Pharmacokinetics and Safety with Bioequivalence of the Nitroglycerin Sublingual Tablets of Two Formulations in Chinese Healthy Subjects: A Bioequivalence Study.

Qinjiao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.